Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX.SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) injectable suspension, for intramuscular useInitial U.S. Approval: 2017
Medication labelWhy this: Advisory · dailymed-other
SHINGRIX is a vaccine indicated for prevention of herpes zoster (HZ) (shingles): •in adults aged 50 years and older. •in adults aged 18 years and older who are or will be at increased risk of HZ due to immunodeficiency or immunosuppression caused by known disease or therapy. Limitations of Use: •SHINGRIX is not indicated for prevention of primary varicella infection (chickenpox).
- generic_name
- zoster vaccine recombinant, adjuvanted
- product_names
- Zoster Vaccine Recombinant, Adjuvanted
- ndc
- 50090-7919, 58160-849, 50090-7919-0
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en